Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gipharma
Saluggia, Vercelli, Italygipharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Gipharma is an Italian contract manufacturing organization (CMO) and pharmaceutical company specializing in the production of small-volume parenterals, liquid, and lyophilized injectable drugs. Founded in 2003 as a spin-off of Nycomed Amersham Sorin, the company is a key manufacturer of radiopharmaceuticals, sterile vials, and cold kits for nuclear medicine imaging. Gipharma's product portfolio includes proprietary generic SPECT radiopharmaceuticals, medical devices for sterile separation, and commercial products like Syner-KINASE (urokinase). Since 2008, Gipharma has operated as a subsidiary of Advanced Accelerator Applications (AAA), which was subsequently acquired by Novartis in 2018.
- Therapeutic areas
- CardiovascularOncology
- Modalities
- RadiopharmaceuticalSmall moleculePeptidesBiologicRecombinant protein
- Industry
- Pharma
02
Partnerships
GE HealthcareCovidienSynermedIBISyner-Medica
Beyond the preview
Go deeper on Gipharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gipharma.